218 related articles for article (PubMed ID: 34398873)
1. Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression.
Aiderus A; Newberg JY; Guzman-Rojas L; Contreras-Sandoval AM; Meshey AL; Jones DJ; Amaya-Manzanares F; Rangel R; Ward JM; Lee SC; Ban KH; Rogers K; Rogers SM; Selvanesan L; McNoe LA; Copeland NG; Jenkins NA; Tsai KY; Black MA; Mann KM; Mann MB
PLoS Genet; 2021 Aug; 17(8):e1009094. PubMed ID: 34398873
[TBL] [Abstract][Full Text] [Related]
2. Integrative transcriptomic analysis for linking acute stress responses to squamous cell carcinoma development.
Nguyen TN; Rajapakshe K; Nicholas C; Tordesillas L; Ehli EA; Davis CM; Coarfa C; Flores ER; Dickinson SE; Curiel-Lewandrowski C; Tsai KY
Sci Rep; 2020 Oct; 10(1):17209. PubMed ID: 33057049
[TBL] [Abstract][Full Text] [Related]
3. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates.
Chitsazzadeh V; Coarfa C; Drummond JA; Nguyen T; Joseph A; Chilukuri S; Charpiot E; Adelmann CH; Ching G; Nguyen TN; Nicholas C; Thomas VD; Migden M; MacFarlane D; Thompson E; Shen J; Takata Y; McNiece K; Polansky MA; Abbas HA; Rajapakshe K; Gower A; Spira A; Covington KR; Xiao W; Gunaratne P; Pickering C; Frederick M; Myers JN; Shen L; Yao H; Su X; Rapini RP; Wheeler DA; Hawk ET; Flores ER; Tsai KY
Nat Commun; 2016 Aug; 7():12601. PubMed ID: 27574101
[TBL] [Abstract][Full Text] [Related]
4. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
5. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
[TBL] [Abstract][Full Text] [Related]
6. CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.
Ichise T; Yoshida N; Ichise H
J Pathol; 2019 Sep; 249(1):39-51. PubMed ID: 30953353
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of aggressive cutaneous squamous cell carcinoma.
Pickering CR; Zhou JH; Lee JJ; Drummond JA; Peng SA; Saade RE; Tsai KY; Curry JL; Tetzlaff MT; Lai SY; Yu J; Muzny DM; Doddapaneni H; Shinbrot E; Covington KR; Zhang J; Seth S; Caulin C; Clayman GL; El-Naggar AK; Gibbs RA; Weber RS; Myers JN; Wheeler DA; Frederick MJ
Clin Cancer Res; 2014 Dec; 20(24):6582-92. PubMed ID: 25303977
[TBL] [Abstract][Full Text] [Related]
8. Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression.
Takeda H; Wei Z; Koso H; Rust AG; Yew CC; Mann MB; Ward JM; Adams DJ; Copeland NG; Jenkins NA
Nat Genet; 2015 Feb; 47(2):142-50. PubMed ID: 25559195
[TBL] [Abstract][Full Text] [Related]
9. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.
Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D
Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390
[TBL] [Abstract][Full Text] [Related]
10. A transposon-based analysis of gene mutations related to skin cancer development.
Quintana RM; Dupuy AJ; Bravo A; Casanova ML; Alameda JP; Page A; Sánchez-Viera M; Ramírez A; Navarro M
J Invest Dermatol; 2013 Jan; 133(1):239-48. PubMed ID: 22832494
[TBL] [Abstract][Full Text] [Related]
11. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Okosun J; Bödör C; Wang J; Araf S; Yang CY; Pan C; Boller S; Cittaro D; Bozek M; Iqbal S; Matthews J; Wrench D; Marzec J; Tawana K; Popov N; O'Riain C; O'Shea D; Carlotti E; Davies A; Lawrie CH; Matolcsy A; Calaminici M; Norton A; Byers RJ; Mein C; Stupka E; Lister TA; Lenz G; Montoto S; Gribben JG; Fan Y; Grosschedl R; Chelala C; Fitzgibbon J
Nat Genet; 2014 Feb; 46(2):176-181. PubMed ID: 24362818
[TBL] [Abstract][Full Text] [Related]
12. miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma.
Gastaldi C; Bertero T; Xu N; Bourget-Ponzio I; Lebrigand K; Fourre S; Popa A; Cardot-Leccia N; Meneguzzi G; Sonkoly E; Pivarcsi A; Mari B; Barbry P; Ponzio G; Rezzonico R
Carcinogenesis; 2014 May; 35(5):1110-20. PubMed ID: 24374827
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
[TBL] [Abstract][Full Text] [Related]
14. Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma.
Pedersen TX; Leethanakul C; Patel V; Mitola D; Lund LR; Danø K; Johnsen M; Gutkind JS; Bugge TH
Oncogene; 2003 Jun; 22(25):3964-76. PubMed ID: 12813470
[TBL] [Abstract][Full Text] [Related]
15. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
[TBL] [Abstract][Full Text] [Related]
16. PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.
Chen L; Hayden MS; Gilmore ES; Alexander-Savino C; Oleksyn D; Gillespie K; Zhao J; Poligone B
Carcinogenesis; 2018 Mar; 39(3):418-428. PubMed ID: 29186361
[TBL] [Abstract][Full Text] [Related]
17. SB Driver Analysis: a Sleeping Beauty cancer driver analysis framework for identifying and prioritizing experimentally actionable oncogenes and tumor suppressors.
Newberg JY; Black MA; Jenkins NA; Copeland NG; Mann KM; Mann MB
Nucleic Acids Res; 2018 Sep; 46(16):e94. PubMed ID: 29846651
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
Fan Y; Bazai SK; Daian F; Arechederra M; Richelme S; Temiz NA; Yim A; Habermann BH; Dono R; Largaespada DA; Maina F
J Hepatol; 2019 Mar; 70(3):470-482. PubMed ID: 30529386
[TBL] [Abstract][Full Text] [Related]
19. TAp63-Regulated miRNAs Suppress Cutaneous Squamous Cell Carcinoma through Inhibition of a Network of Cell-Cycle Genes.
Davis AJ; Tsinkevich M; Rodencal J; Abbas HA; Su XH; Gi YJ; Fang B; Rajapakshe K; Coarfa C; Gunaratne PH; Koomen JM; Tsai KY; Flores ER
Cancer Res; 2020 Jun; 80(12):2484-2497. PubMed ID: 32156775
[TBL] [Abstract][Full Text] [Related]
20. Clonal expansion analysis of transposon insertions by high-throughput sequencing identifies candidate cancer genes in a PiggyBac mutagenesis screen.
Friedel RH; Friedel CC; Bonfert T; Shi R; Rad R; Soriano P
PLoS One; 2013; 8(8):e72338. PubMed ID: 23940809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
